BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has announced an upcoming corporate presentation by Executive Chair Jayne Shaw at the 18th Bioshares Biotech Summit. The presentation will focus on pioneering advancements in breast cancer diagnostics and will take place at the Esplanade Hotel in Fremantle, Western Australia. Investors and stakeholders are anticipating insights into the company’s strategic direction and innovations.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
